Research ArticleCancer

Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy

See allHide authors and affiliations

Science Translational Medicine  17 Jun 2020:
Vol. 12, Issue 548, eaav9760
DOI: 10.1126/scitranslmed.aav9760

Article Information

vol. 12 no. 548

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication November 7, 2018
  • Resubmitted December 9, 2019
  • Accepted for publication May 4, 2020
  • .

Author Information

  1. Adriana De La Fuente1,*,
  2. Serena Zilio1,*,
  3. Jimmy Caroli2,
  4. Dimitri Van Simaeys1,
  5. Emilia M. C. Mazza2,,
  6. Tan A. Ince3,
  7. Vincenzo Bronte4,
  8. Silvio Bicciato2,
  9. Donald T. Weed5 and
  10. Paolo Serafini1,5,
  1. 1Department of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
  2. 2Department of Life Sciences, University of Modena and Reggio Emilia, Modena 41100, Italy.
  3. 3Department of Pathology, Weill Cornell Medicine, Cornell University and New York Presbyterian Brooklyn Methodist Hospital, NY 11215, USA.
  4. 4Department of Medicine, Verona University Hospital, Verona 37100, Italy.
  5. 5Department of Otolaryngology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  1. Corresponding author. Email: pserafini{at}med.miami.edu
  • * These authors contributed equally to this work.

  • Present address: Laboratory of Translational Immunology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.

Altmetric

Article usage

Article usage: June 2020 to October 2020

AbstractFullPdf
Jun 20203963917354
Jul 20202489896
Aug 20201194846
Sep 20202369153
Oct 2020882717

Stay Connected to Science Translational Medicine